 logo |
Biotec Pharmacon is a biopharmaceutical company that develops and manufactures new immunomodulatory products and cold adapted marine enzymes. The company focuses on new and effective solutions within wound care, cancer therapies and other immune related disease areas, and aspires to become a leading supplier of novel enzymes for diagnostics and genetic research. |
The shares of Biotec Pharmacon ASA are listed on the Oslo Stock Exchange. The listing took place on 4 November 2005. The ticker symbol for Biotec Pharmacon is BIOTEC.
Click here for share price information from the Oslo Stock Exchange.
Biotec Pharmacon has 28,552,816 shares outstanding with a nominal value of NOK 1 per share.
2007: Public share issue: 2,148,900 shares
2010: Private placement: 3,500,000 shares
The share registrar is:
Fokus Bank, Verdipapirservice, P.O. Box 1171 Sentrum, 0107 Oslo, Norway.
For Investor Relations inquiries, please contact CEO Svein W. F. Lien, P.O. Box 6463, NO-9294 Tromsø, telephone +47 922 89 323.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it for inquiries by e-mail.
